Boon Chin Heng

15.3k citations
322 papers · 11.6k indexed · 3 hit papers · h-index 61

Boon Chin Heng

318 papers receiving 11.4k citations

Hit Papers

Multifunctional PtCuTe Nano...1542017202620202023100200300

Peers

Boon Chin Heng
Comparison fields: 5 of 168
  • Orthopedics and Sports Medicine 1.6k
  • Biomaterials 2.2k
  • Urology 938
  • Genetics 1.6k
  • Rheumatology 1.4k
Replace Anita Ignatius with:
Anita Ignatius Germany
Hongwei Ouyang China
Marcel Karperien Netherlands
Yu Wang China
Heinz Redl Austria
Jérôme Guicheux France
Julie Glowacki United States
Jiang Peng China
Gianluca Giavaresi Italy
Manuela E. Gomes Portugal
Boon Chin Heng relative to Anita Ignatius Germany Anita Ignatius's profile →
Citations per field
00.5×1.5×
Anita Ignatius · 1×
Citations per year

Countries citing papers authored by Boon Chin Heng

Since Specialization
Citations

This map shows the geographic impact of Boon Chin Heng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boon Chin Heng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boon Chin Heng more than expected).

Fields of papers citing papers by Boon Chin Heng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boon Chin Heng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boon Chin Heng. The network helps show where Boon Chin Heng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Boon Chin Heng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Boon Chin Heng Line = papers co-authored together Boon Chin Heng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20257
2 20257
3 20241
4 202410
5 20242
6 202432
7 20243
8 20236
9 202342
10 202378
11 20232
12 202242
13 202135
14 202112
15 20209
16 201923
17 201840
18 2016110
19 2015157
20 200821

About Boon Chin Heng

Boon Chin Heng is a scholar working on Genetics, Orthopedics and Sports Medicine and Urology, having authored 322 papers that have together received 11.6k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (61 papers), Mesenchymal stem cell research (46 papers), 3D Printing in Biomedical Research (42 papers), Bone Tissue Engineering Materials (41 papers), Tendon Structure and Treatment (34 papers), Tissue Engineering and Regenerative Medicine (33 papers), Osteoarthritis Treatment and Mechanisms (30 papers) and Knee injuries and reconstruction techniques (26 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.6k citations), Biomaterials (2.2k citations) and Urology (938 citations). Boon Chin Heng has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Tong Cao, Hongwei Ouyang, Zi Yin, Xiao Chen, Hua Liu, Weiliang Shen, Say Chye Joachim Loo, Zigang Ge, Xuliang Deng and Hong Ouyang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026